Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
PUT
Dollar General
DG
$28B
| $1.83M | ﹤0.01% |
17,700
-232,300
| -93% | -$25.5M |
|
2927
Precigen
PGEN
$2.24B
| $1.83M | ﹤0.01% |
555,856
+249,438
| +81% | +$704K |
|
2928
CALL
ConocoPhillips
COP
$147B
| $1.83M | ﹤0.01% |
19,300
-8,400
| -30% | -$794K |
|
2929
Peoples Bancorp
PEBO
$1.5B
| $1.82M | ﹤0.01% |
60,690
-21,332
| -26% | -$647K |
|
2930
US Physical Therapy
USPH
$1.2B
| $1.81M | ﹤0.01% |
21,338
-9,654
| -31% | -$773K |
|
|
SEZL
2931
Sezzle
SEZL
$5.2B
| $1.8M | ﹤0.01% |
22,669
-6,499
| -22% | -$746K |
|
2932
Driven Brands
DRVN
$2.35B
| $1.8M | ﹤0.01% |
111,796
-24,487
| -18% | -$427K |
|
2933
South Plains Financial
SPFI
$845M
| $1.79M | ﹤0.01% |
46,374
+848
| +2% | +$33.1K |
|
2934
Cerus
CERS
$433M
| $1.78M | ﹤0.01% |
1,120,927
-300,293
| -21% | -$406K |
|
|
CMA
2935
PUT
DELISTED
Comerica
CMA
| $1.78M | ﹤0.01% |
+26,000
| New | +$1.75M |
|
|
AIFC
2936
AI Financial Corp
AIFC
$57.6M
| $1.78M | ﹤0.01% |
662,032
+661,356
| +97,834% | +$3.96M |
|
|
DFTX
2937
Definium Therapeutics
DFTX
$5.78B
| $1.78M | ﹤0.01% |
150,605
-24,628
| -14% | -$230K |
|
2938
Calumet Specialty Products
CLMT
$3.85B
| $1.77M | ﹤0.01% |
97,186
-51,835
| -35% | -$853K |
|
2939
Amphastar Pharmaceuticals
AMPH
$879M
| $1.77M | ﹤0.01% |
66,494
-15,593
| -19% | -$403K |
|
2940
Clover Health Investments
CLOV
$2.2B
| $1.77M | ﹤0.01% |
577,952
-222,722
| -28% | -$636K |
|
2941
PUT
nVent Electric
NVT
$24.9B
| $1.77M | ﹤0.01% |
+17,900
| New | +$1.55M |
|
2942
BrightView Holdings
BV
$1.22B
| $1.76M | ﹤0.01% |
131,697
-42,521
| -24% | -$631K |
|
2943
Dime Commercial Bancshares
DCOM
$1.8B
| $1.75M | ﹤0.01% |
58,800
-31,868
| -35% | -$934K |
|
2944
Invesco China Technology ETF
CQQQ
$3.03B
| $1.75M | ﹤0.01% |
29,600
+13,600
| +85% | +$680K |
|
2945
Cadre Holdings
CDRE
$1.32B
| $1.74M | ﹤0.01% |
47,750
-47,256
| -50% | -$1.52M |
|
2946
CALL
SiriusXM
SIRI
$9.98B
| $1.74M | ﹤0.01% |
74,840
| – | – |
|
2947
Zillow
ZG
$7.94B
| $1.74M | ﹤0.01% |
23,358
-3,258
| -12% | -$256K |
|
2948
Bank First Corp
BFC
$1.69B
| $1.74M | ﹤0.01% |
14,319
-3,288
| -19% | -$409K |
|
2949
Amalgamated Financial
AMAL
$1.48B
| $1.73M | ﹤0.01% |
63,872
-130,443
| -67% | -$3.88M |
|
2950
Allient
ALNT
$1.49B
| $1.73M | ﹤0.01% |
38,715
+6,370
| +20% | +$272K |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.